ImmunityBio IBRX
NASDAQ IBRX
$8.83 +0.31 (+3.64%)
At close: Sep 29, 2026 · 4:00 PM EDT

ImmunityBio (IBRX) Acquisitions (2015)

Updated

ImmunityBio's Acquisitions came in at $1 million for FY2024.

Analysis

ImmunityBio (IBRX) Acquisitions (2015) Analysis & Trends

  • The FY2024 figure represents the highest annual Acquisitions since FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -17.24 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -23.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.21 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 ImmunityBio 8.97 Bn 7.74 Bn 50.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 1.82 Mn
API Access

ImmunityBio Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=IBRX&period=max&api_key=YOUR_API_KEY